Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis

Journal of Clinical Psychiatry

Volumn 68, Issue 5, 2007, Pages 767-774

  Wade, Darryl ^a,b   Harrigan, Susy ^a,c   McGorry, Patrick D ^a,b,c   Burgess, Philip M ^d   Whelan, Greg ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; SOCIAL STATUS; SUBSTANCE ABUSE; ADDICTION; CLASSIFICATION; HOSPITALIZATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SOCIAL BEHAVIOR;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SOCIAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS;

EID: 34249706259     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0517     Document Type: Article

References (28)

1. Blanchard JJ, Brown SA, Horan WP, et al. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 2000;20:207-234
2. Lambert M, Conus P, Lubman DI, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005;112:141-148
3. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994;51:273-279
4. Sorbara F, Liraud F, Assens F, et al. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur Psychiatry 2003;18:133-136
5. Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR. Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry 1994;164:679-681
6. Swofford CD, Kasckow JW, Scheller-Gilkey G, et al. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res 1996;20:145-151
7. Sevy S, Robinson DG, Solloway S, et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 2001;104:367-374
8. Kovasznay B, Fleischer J, Tanenberg-Karant M, et al. Substance use disorder and the early course of illness in schizophrenia and affective psychosis. Schizophr Bull 1997;23:195-201
9. Buhler B, Hambrecht M, Loffler W, et al. Precipitation and determination of the onset and course of schizophrenia by substance abuse: a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res 2002;54:243-251
10. Chouljian TL, Shumway M, Balancio E, et al. Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status. Ann Clin Psychiatry 1995;7:19-24
11. Caspari D. Cannabis and schizophrenia: results of a follow-up study. Eur Arch Psychiatry Clin Neurosci 1999;249:45-49
12. Birchwood M, Todd P, Jackson C. Early intervention in psychosis: me critical period hypothesis. Br J Psychiatry Suppl 1998;172:53-59
13. Wade D, Harrigan S, Edwards J, et al. Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophr Res 2006;81:145-150
14. Wade D, Harrigan S, Edwards J, et al. Substance misuse in first-episode psychosis: 15-mondi prospective follow-up study. Br J Psychiatry 2006;189:229-234
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association; 1994
16. McGorry PD, Singh BS, Copolov DL, et al. Royal Park Multidiagnostic Instrument for Psychoses: part II development, reliability, and validity. Schizophr Bull 1990;16:517-536
17. McGovern MP, Morrison DH. The Chemical Use, Abuse, and Dependence Scale (CUAD): rationale, reliability, and validity. J Subst Abuse Treat 1992;9:27-38
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
19. Appleby L, Dyson V, Altman E, et al. Utility of the Chemical Use, Abuse, and Dependence Scale in screening patients with severe mental illness. Psychiatr Serv 1996;47:647-649
20. Lukoff D, Liberman RP, Nuechterlein KH. Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 1986;12:578-602
21. Andreasen NC. Scale for me Assessment of Negative Symptoms (SANS). Iowa City, Iowa: University of Iowa; 1981
22. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 1984;10:388-398
23. Goldman HH, Skodol AE, Lave TR. Revising Axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149:1148-1156
24. Wade D, Harrigan S, Harris MG, et al. Pattern and correlates of inpatient admission during the initial acute phase of first-episode psychosis. Aust N Z J Psychiatry 2006;40:429-436
25. Voruganti LN, Slomka P, Zabel P, et al. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Res 2001;107:173-177
26. Wade D, Harrigan S, Edwards J, et al. Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Aust N Z J Psychiatry 2005;39:892-898
27. Drake RE, Brunette MF. Complications of severe mental illness related to alcohol and drug use disorders. Recent Dev Alcohol 1998;14:285-299
28. Edwards J, Elkins K, Hinton M, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand 2006;114:109-117